Quick Answer
CareDx, Inc. reported R&D Expense of $71.43 million for fiscal year 2025.
CareDx, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $71.43M | -1.5% |
| 2024 | $72.51M | -12.0% |
| 2023 | $82.42M | -8.8% |
| 2022 | $90.39M | +18.1% |
| 2021 | $76.53M | +56.4% |
| 2020 | $48.94M | +59.4% |
| 2019 | $30.71M | +111.6% |
| 2018 | $14.51M | +17.2% |
| 2017 | $12.39M | +0.0% |
| 2016 | $12.38M | +32.7% |
| 2015 | $9.33M | +142.7% |
| 2014 | $3.85M | +21.1% |
| 2013 | $3.18M | -33.2% |
| 2012 | $4.75M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.77M | -4.1% | -0.4% |
| June 30, 2025 | $16.83M | -14.5% | -9.1% |
| March 31, 2025 | $18.52M | -1.0% | +5.9% |
| September 30, 2024 | $17.49M | -8.0% | -11.2% |
| June 30, 2024 | $19.69M | -2.7% | +5.2% |
| March 31, 2024 | $18.71M | -23.2% | -1.5% |
| September 30, 2023 | $19.00M | -14.8% | -6.1% |
| June 30, 2023 | $20.23M | -10.6% | -16.9% |
- CareDx, Inc. showed a decrease of -1.5% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, CareDx, Inc.’s r&d expense has grown by 1403.1% (from $4.75 million to $71.43 million).
- The most recent figure is from CareDx, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: